Toward a more effective genetic test for autism

© Tetra Images/Corbis
Baby playing with DNA model --- Image by © Tetra Images/Corbis

Expecting parents who have one child or other family members with an autism spectrum disorder often request genetic testing to determine their unborn child’s risk for autism. Currently, however, the most frequently used genetic tests—karyotyping, which examines a sample of cells for abnormalities and testing for Fragile X syndrome, a condition that can cause developmental problems and is known as a leading genetic cause of autism spectrum disorders—most often come up negative. Yet another technique, known as chromosomal microarray analysis (CMA), which examines the entire genome, homing in on tiny variations in DNA sequences, may offer better, more accurate results, according to a large-scale study published in the April issue of the journal Pediatrics.

Researchers from Children’s Hospital Boston and Autism Consortium analyzed the results of the three types of genetic testing on a group of 933 children between the ages of 13 months and 22 years, who had all been diagnosed with an autism spectrum disorder. (Roughly half of the patients had been diagnosed with autism, and half with a condition known as pervasive developmental disorder not otherwise specified (PDD-NOS), and a small group, about 3% of patients, had been diagnosed with Asperger’s syndrome.)

Though all of the children included in the study had been diagnosed with an autism spectrum disorder, the karyotyping test showed abnormal results for just 2.23% of study participants, and tests for Fragile X syndrome yielded abnormal results in just .46% of cases. In contrast, the CMA test showed abnormal results for 7.3% of patients.

The findings suggest that CMA testing is substantially more effective than the two currently used genetic tests. What’s more, because of its detailed assessment of the entire genome, CMA testing may help autism researchers and specialists home in on very specific genetic DNA variations causing autism and tailor treatments accordingly, the researchers say. That’s a promising development considering that some 15% of autism cases have a genetic cause.

Yet, even though CMA testing may produce more accurate results—yielding genetic diagnoses in 5% more cases than the other two tests combined, according to researchers’estimates—it still won’t provide any answers for the vast majority of people given the test. Still, in the ongoing battle toward better understanding and diagnosis of autism, it’s a step forward.

Related Topics: autism spectrum disorders, genetics, Autism
  • Latest on Healthland

    Photodisc / Getty Images

    Treating Cancer Is O.K. During Pregnancy

    Researchers have encouraging news for women who find themselves in a very frightening situation: having cancer while pregnant.

    Doctors Cheating in Dermatology ExamsCNN Health

    Nicholas Eveleigh / Getty Images

    Hold the Mystery Meat! Military Food Gets an Upgrade

    Military mess halls soon will be serving more fruits, vegetables and low-fat dishes under the first program in 20 years to improve nutrition standards across the armed services.

  • amdachel

    This study has gotten major coverage by the media and I’m not sure why. TIME tells us, “The findings suggest that CMA testing is substantially more effective than the two currently used genetic tests. . . . That’s a promising development considering that some 15% of autism cases have a genetic cause.”

    For the other 85% of cases, it looks like parents are left with the usual comment, “Autism has no known cause,” that we’ve heard for endless years or as Tiffany O’Callaghan puts it, “It still won’t provide any answers for the vast majority of people give the test. Still, in the ongoing battle toward better understanding and diagnosis of autism, it’s a step forward.”

    It’s hard to imagine how this is a step forward. Autism is now a raging epidemic in the U.S., affecting one percent of children/one in every 70 boys and experts continue to have no answers. A once-rare disorder is now so common that everyone knows someone with an autistic child and no one can tell us why. How bad do the numbers have to get before autism is addressed as a national health crisis that could only be happening because of environmental factors? How long will we pretend we can find the answer to autism with genetic testing?

    Anne Dachel
    Media editor: Age of Autism http://www.ageofautism.com/

  • slothloveschunk

    Perfectly said.

    “How bad do the numbers have to get before autism is addressed as a national health crisis that could only be happening because of environmental factors? How long will we pretend we can find the answer to autism with genetic testing?”

    Precisely. The average person has traces of over 700 chemicals in their bloodstream and approximately 100,000 synthetic chemicals are in existence. No combination (i.e. synergism) of these chemicals has ever been tested, nor would it even be practical to do so. The most frightening example of this type of pollution is the breast milk of Inuit mothers. If it were ever bottled and sold as a food product, not only would it not meet FDA standards, but it would be classified as toxic waste! For more details, please read the Hundred-Year Lie by Randall Fitzgerald to educate yourself, and to enable you to protect your loved ones from this environmental onslaught.

    http://www.hundredyearlie.com/

  • sallyn423

    What is not mentioned in the original blog that one should take into account, and mentioned in other press releases on this subject is “The test is not intended to replace current screening tests, but complement them in an overall comprehensive care plan. The detection of more genes associated with autism could bring a better understanding of the cause of autism spectrum disorders and could lead to better treatments tailored to each patient.”

    In diagnosing fragile X, the gold standard, until otherwise noted from Fragile X experts, will be the FMR1 DNA test (Southern Blot with PCR Analysis, and that may one day change based on the results of the test they are using for the Newborn Screening study).

    As noted in the American College of Medical Genetics, Diagnostics and Carrier testing, Practice Guidelines, revised in 2005, http://www.acmg.net/StaticContent/StaticPages/FragileX.pdf “In a small number of individuals with FXS, mechanisms other than trinucleotide expansion, such as deletion or point mutation, are responsible for the syndrome. In these cases, linkage studies, cytogenetic, sequencing and/or assays designed to identify rare mutations and deletions may provide important information for relatives.” This is the only time a cytogenetic (chromosome analysis) test can be trusted to be accurate in a fragile X diagnosis.

    Someone can correct me if I’m wrong, but I believe the Chromosomal Microarray Analysis (CMA) is just a new improved cytogenetic test (chromosome analysis) and as noted in the ACMG Practice Guidelines listed above the cytogenetic test was created prior to the discovery of the fragile X gene, and has proven unreliable in diagnosing fragile X, but it can be used to identify Fragile X when it’s due to a deletion of the gene (which is rare). The FMR1 DNA test is 99% accurate in diagnosis, the cytogenetic test I believe is less than 50% accurate, to me that’s a huge difference and I’ve meet far too many families who were given a false negative diagnosis because the FMR1 DNA test wasn’t done, the doctor ran only a cytogenetic (chromosome analysis) test.

    This new test may be a better tool to identify those with Angelman or Rett Syndrome, or those with suspect mutations in newly discovered suspect genes/chromosomes.

    In the fragile X world, at the hands of inexperienced professionals when it comes to fragile X diagnoses could there be far too many false negatives, I’d guess yes, all depends – I wonder in this study did they compare the results to actual FMR1 DNA tests, were they the same? That’s what I’d like to know. And, remember the quote above “This test is not intended to replace current screening tests, but …” If you have a fragile X test done, and they haven’t given you “CGG” repeat numbers for the alleles I’d be very concerned that they didn’t do a FMR1 DNA test, something to think about.

    And, if you’ve never tested for fragile X, never ruled it in or out, consider having the FMR DNA test done.

    And, if by chance someone screwed up, ran the wrong test and you got the wrong news, I’d consider suing, I’m just a mom yet I understand the practice guidelines (which originated in 1994) there is no excuse why any medical professional can’t get it right. A correct diagnosis may change your treatment plan, the therapies you’ll seek out.

  • francisdane

    One of my cousins has a son with high functioning Asperger’s syndrome. If you didn’t know what Aspergers was or the symptoms, you’d just think he was just odd. He may make it in the world, but may need some sort of support. No one in my extended family every had autism or Asperger’s, I just don’t understand what’s happening here. My grade school in the 50′s and early 60′s had a special education class room next to ours, we shared a bathroom. I used to play with the kids at recess. I think most of them had Down’s syndrome. I don’t remember any autistic children. It could be that the austic children at the far end of the spectrum [non-verbal, head bangers] were not in the class, but I just don’t remember autism being a problem to this extent it is today. It’s so heartbreaking to see these poor children. More attention must be paid to this problem.

blog comments powered by Disqus